Univar Inc. on Wednesday priced its IPO at 35 million shares at $22 each via joint book runners Deutsche Bank Securities, Goldman, Sachs & Co. and BofA Merrill Lynch. Univar, a chemical distributor, is selling 20 million shares while certain stockholders are offering 15 million. Univar shares will trade on the NYSE under the ticker symbol “UNVR” later today. Univar is a portfolio company of CVC Capital Partners.
DOWNERS GROVE, Ill. – June 17, 2015 – Univar Inc., a global chemical distributor and provider of value-added services, announced today the pricing of its initial public offering of 35,000,000 shares of common stock at a price to the public of $22.00 per share. Univar Inc. will sell 20,000,000 shares and certain of our stockholders will sell 15,000,000 shares in the offering. The shares are expected to begin trading on the New York Stock Exchange under the symbol “UNVR” on June 18, 2015. The underwriters have a 30-day option to purchase up to an additional 5,250,000 shares of common stock from certain of our stockholders.
Univar Inc. intends to use the net proceeds of the offering, and a concurrent private placement, to redeem, repurchase, or otherwise acquire or retire $650 million of its outstanding Subordinated Notes due in 2017 and 2018 and pay associated fees and expenses, and for general corporate purposes. Univar Inc. will not receive any proceeds from the sale of shares by the selling stockholders.
Deutsche Bank Securities, Goldman, Sachs & Co., and BofA Merrill Lynch are acting as joint book-running managers. Additional book-running managers are Barclays Capital Inc., Credit Suisse Securities (USA) LLC, J.P. Morgan Securities LLC, Jefferies LLC, and Morgan Stanley & Co. LLC.
The offering will be made only by means of a prospectus. Copies of the prospectus relating to the securities being offered may be obtained, when available, from:
· _Deutsche Bank Securities Inc., Attention: Prospectus Group, 60 Wall Street, New York, NY 10005-2836, by email to firstname.lastname@example.org, or by telephone at (800) 503-4611.
Pg. 2 – Univar Inc. Prices Initial Public Offering of Common Stock
· _Goldman, Sachs & Co., Attention: Prospectus Department, 200 West Street, New York, NY 10282, by email to email@example.com, by telephone at (866) 471-2526, or by fax at (212) 902-9316.
A registration statement relating to these securities has been filed with, and declared effective by, the U.S. Securities and Exchange Commission (SEC). This press release shall not constitute an offer to sell or the solicitation of an offer to buy nor shall there be any sale of these shares in any state in which such offer, solicitation or sale would be unlawful, prior to registration or qualification under the securities laws of any state.
About Univar Inc.
Founded in 1924, Univar is a global distributor of specialty and basic chemicals from more than 8,000 producers worldwide. Univar operates more than 700 distribution facilities throughout North America, Western Europe, the Asia-Pacific region, and Latin America, supported by a global network of sales and technical professionals. With a broad portfolio of products and value-added services, and deep technical and market expertise, Univar delivers the tailored solutions customers need through one of the most extensive chemical distribution networks in the world. Univar is Chemistry DeliveredSM.
This press release includes “forward-looking statements,” including with respect to the proposed initial public offering, within the meaning of Section 27A of the Securities Act and Section 21E of the Securities Exchange Act of 1934, as amended. Forward-looking statements are subject to known and unknown risks and uncertainties, many of which may be beyond our control. We caution you that the forward-looking information presented in this press release is not a guarantee of future events, and that actual events may differ materially from those made in or suggested by the forward-looking information contained in this press release. In addition, forward-looking statements generally can be identified by the use of forward-looking terminology such as “may,” “plan,” “seek,” “comfortable with,” “will,” “expect,” “intend,” “estimate,” “anticipate,” “believe” or “continue” or the negative thereof or variations thereon or similar terminology. Any forward-looking information presented herein is made only as of the date of this press release, and we do not undertake any obligation to update or revise any forward-looking information to reflect changes in assumptions, the occurrence of unanticipated events, or otherwise.